Inovio Pharmaceuticals, Inc. - Common Stock — Balance Sheet (NASDAQ:INO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 539.77 M495.94 M348.53 M170.95 M113.2 M74.31 M Total liabilities 78.63 M96.27 M126.17 M53.6 M44.69 M50.21 M Total equity 461.14 M399.67 M222.36 M117.35 M68.5 M24.1 M Total liabilities & shareholders' equities 539.77 M495.94 M348.53 M170.95 M113.2 M74.31 M Total debt ———16.77 M—— Net debt ———-128.53 M——

News

Inovio: All Eyes On INO-3107 As Binary FDA Decision Looms (NASDAQ:INO)

Inovio Pharmaceuticals, Inc. (INO) Q1 2026 Earnings Call Transcript

Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call - Inovio Pharmaceuticals (NASDAQ:INO)

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y

RARE Q1 Loss Wider Than Expected, Sales Down Y/Y on Seasonal Effect

NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up

Viatris Gears Up to Report Q1 Earnings: What's in the Cards?

Catalyst Pharmaceutics to Report Q1 Earnings: Is a Beat in the Cards?

Pacira Q1 Earnings Miss Estimates on Higher Costs, Revenues Rise Y/Y

Zoetis Gears Up to Report Q1 Earnings: Is a Beat in the Cards?